Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.04
+0.01 (0.17%)
Nov 9, 2026, 2:38 PM EST - Market open
Inogen Revenue
Inogen had revenue of $77.19M in the quarter ending September 30, 2026, a decrease of -16.45%. This brings the company's total for the last twelve months to $339.11M, down -2.28% year-over-year. In the year 2025, Inogen had annual revenue of $348.67M with 3.86% growth. That makes Inogen the 13,381st largest company in the world by revenue and 2,502nd in the United States.
Revenue (ttm)
$339.11M
Revenue Growth
-2.28%
P/S Ratio
0.45
Revenue / Employee
$471,525
Employees
753
Market Cap
160.29M
Revenue by Geography
- United States 209.84M 60.2%
- Europe 118.00M 33.8%
- Other International 20.82M 6.0%
Fiscal year ended Dec 31, 2025 See the full Inogen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 348.67M | 12.96M | 3.86% |
| Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
| Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
| Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
| Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
| Dec 31, 2020 | 308.49M | -53.46M | -14.77% |
| Dec 31, 2019 | 361.94M | 3.83M | 1.07% |
| Dec 31, 2018 | 358.11M | 108.67M | 43.57% |
| Dec 31, 2017 | 249.44M | 46.61M | 22.98% |
| Dec 31, 2016 | 202.83M | 43.82M | 27.56% |
| Dec 31, 2015 | 159.01M | 46.47M | 41.29% |
| Dec 31, 2014 | 112.54M | 37.09M | 49.17% |
| Dec 31, 2013 | 75.44M | 26.87M | 55.31% |
| Dec 31, 2012 | 48.58M | 17.94M | 58.57% |
| Dec 31, 2011 | 30.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 203.35M |
| Neuronetics | 159.76M |
| Quanterix | 153.41M |
| RxSight | 121.83M |
| Owlet | 114.41M |
| Pulmonx | 88.78M |
| Standard BioTools | 84.43M |
| Electromed | 73.78M |
INGN News
- 3 days ago - Inogen trading resumes - TheFly
- 3 days ago - Inogen trading halted, volatility trading pause - TheFly
- 3 days ago - Inogen Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Inogen Earnings release: Q3 2026 - Filings
- 3 days ago - Inogen Slides: Q3 2026 - Filings
- 3 days ago - Inogen reports Q3 adjusted EPS (2c), consensus (14c) - TheFly
- 3 days ago - Inogen sees Q4 revenue $65M-$68M, consensus $84M - TheFly
- 3 days ago - Inogen sees FY26 revenue $298M-$301M, consensus $356.4M - TheFly